Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women

Nadia M Ikumi, Thokozile R Malaba, Komala Pillay, View ORCID ProfileMarta C Cohen, Hlengiwe P Madlala, Mushi Matjila, Dilly Anumba, Landon Myer, Marie-Louise Newell, Clive M Gray, for the PIMS Study Group
doi: https://doi.org/10.1101/2020.06.15.20131615
Nadia M Ikumi
1Division of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thokozile R Malaba
2Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Komala Pillay
3Division of Anatomical Pathology, Department of Pathology, University of Cape Town, Cape Town, South Africa
4National Health Laboratory Services, Groote Schuur Hospital, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta C Cohen
5Department of Histopathology, Sheffield Children’s NHS Foundation Trust, Sheffield, UK
6Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK, Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marta C Cohen
Hlengiwe P Madlala
2Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mushi Matjila
7Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dilly Anumba
8Academic Unit of Reproductive and Developmental Medicine, University of Sheffield, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Landon Myer
2Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Louise Newell
9School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
10School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clive M Gray
1Division of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
4National Health Laboratory Services, Groote Schuur Hospital, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: clive.gray@uct.ac.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To examine the association between timing of ART initiation in HIV-infected women and placental histopathology.

Design A nested sub-study in a larger cohort of HIV-infected women which examined the association between ART status and birth outcomes.

Methods Placentas (n=130) were examined for histopathology from two ART groups: stable (n=53), who initiated ART before conception and initiating (n=77), who started ART during pregnancy (median [IQR] 15 weeks gestation [11-18]). Using binomial regression we quantified associations between ART initiation timing with placental histopathology and pregnancy outcomes.

Results One-third of all placentas were <10th percentile weight-for-gestation and there was no significant difference between ART groups. Placental diameter, thickness, cord insertion position and fetal-placental weight ratio were also similar by group. However, placentas from the stable group showed increased maternal vascular malperfusion (MVM) (39.6% vs 19.4%), and decreased weight (392g vs 422g, p=0.09). MVM risk was twice as high (RR 2.03 [95% CI: 1.16 - 3.57]; p=0.01) in the stable group; the increased risk remaining significant when adjusting for maternal age (RR 2.04 [95% CI: 1.12 - 3.72]; p=0.02). Furthermore, MVM was significantly associated with pre-term delivery (PTD) and low birth weight (LBW) (p=0.002 and p<0.0001, respectively).

Conclusion Preconception initiation of ART was associated with an increased MVM risk, and may contribute to placental dysfunction. The association between MVM with PTD and LBW suggests that a placenta-mediated mechanism likely links the putative association between long-term use of ART and adverse birth outcomes.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01 HD080385 (PIMS Prematurity Immunology in HIV-Infected Infants and their Infants Study) National Institute for Health Research (NIHR) (17/63/26) using UK Government aid to support global health research and by the Academy of Medical Sciences networking grant.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Cape Town, Faculty of Health Sciences Human Research Ethics Committee (UCT-HREC) project #739/2014 University of Southampton Faculty of Medicine Ethics Committee project # 12542 PIMS

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Co-First Authors

  • Conflict of interest statement The authors report no conflict of interest.

  • Funding Support: The research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01 HD080385 (PIMS Prematurity Immunology in HIV-Infected Women and their Infants Study); also in part by the National Institute for Health Research (NIHR) (17/63/26) using UK Government aid to support global health research and by the Academy of Medical Sciences networking grant. The views expressed in this publication are those of the author(s) and not necessarily those of the NICH NIH, NIHR or the UK Department of Health and Social Care.

Data Availability

The data collected in this study will be available to external investigators interested in collaboration upon submission and approval of a data analysis plan. Requests for data available within PIMS or to submit a request for additional data collection should be submitted to M.Newell{at}soton.ac.uk and Landon.Myer{at}uct.ac.za and will be reviewed by the study steering committee

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 21, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women
Nadia M Ikumi, Thokozile R Malaba, Komala Pillay, Marta C Cohen, Hlengiwe P Madlala, Mushi Matjila, Dilly Anumba, Landon Myer, Marie-Louise Newell, Clive M Gray, for the PIMS Study Group
medRxiv 2020.06.15.20131615; doi: https://doi.org/10.1101/2020.06.15.20131615
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women
Nadia M Ikumi, Thokozile R Malaba, Komala Pillay, Marta C Cohen, Hlengiwe P Madlala, Mushi Matjila, Dilly Anumba, Landon Myer, Marie-Louise Newell, Clive M Gray, for the PIMS Study Group
medRxiv 2020.06.15.20131615; doi: https://doi.org/10.1101/2020.06.15.20131615

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (47)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4856)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (629)
  • Health Policy (320)
  • Health Systems and Quality Improvement (204)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5339)
  • Intensive Care and Critical Care Medicine (330)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (780)
  • Public and Global Health (1816)
  • Radiology and Imaging (324)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)